Current Telix Pharmaceuticals forecasts and price targets in August 2026
Ø Analyst Price Targets
17.24 USD
+70.52 %
Median
16.42 USD
+62.41 %
Max
35.70 USD
Min
17.17 USD
Last Price
10.11 USD
Buy
16
Hold
1
Sell
0
The average target price for Telix Pharmaceuticals is 17.24 USD. (+70.52 % above the current price)
The median price target of Telix Pharmaceuticals is 16.42 USD.
Stock analysts from many renowned investment banks are closely examining the Telix Pharmaceuticals stock. They conclude their professional Telix Pharmaceuticals stock analyses with a clear recommendation for the Telix Pharmaceuticals stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-03-01 | 16 | 1 | 0 | — |
| 2026-02-01 | 16 | 1 | 0 | 17.24 USD |
| 2026-02-01 | 16 | 1 | 0 | 17.74 USD |
| 2026-01-01 | 15 | 2 | 0 | 18.59 USD |
| 2025-12-01 | 15 | 1 | 0 | 19.25 USD |
| 2025-12-01 | 15 | 1 | 0 | 20.10 USD |
Telix Pharmaceuticals Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Telix Pharmaceuticals in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 984.00 M USD | 12.00 M USD | 0.04 USD |
| 2027e | 1.14 B USD | 30.00 M USD | 0.09 USD |
| 2028e | 1.33 B USD | 87.00 M USD | 0.26 USD |